Paul Kluetz

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Paul Kluetz
May 3, 2025, 20:51 | Blog
Paul Kluetz: I am pleased to announce that I am starting a new position as Chief Medical Officer at Paradigm Health
Paul Kluetz, Chief Medical Officer at Paradigm Health, shared on LinkedIn: "I am pleased to…
Oct 11, 2024, 16:19 | Insight
Myeloma Paper of the Day, October 11th, suggested by Robert Orlowski
Robert Orlowski shared about the Myeloma Paper of the Day. Read about the article on…
Aug 21, 2024, 16:13 | Blog
New Friends of Cancer Research on Alignment of methodologies analyzing real-world data
Friends of Cancer Research shared on LinkedIn: "New Friends of Cancer Research manuscript in JCO Clinical…
Jul 29, 2024, 13:24 | Insight
Gautam Mehta et al. summarize the FDA accelerated approval of fam-trastuzumab deruxtecan-nxki - FDA Oncology
FDA Oncology shared a post on X about a paper titled "FDA approval summary: fam-trastuzumab…
Jul 25, 2024, 00:46 | Blog
FDA-AACR Oncology Educational Fellowship helped four alumni develop their career trajectories
AACR posted on X/Twitter about recent paper by Timil Patel et al., commenting: "A Clinical Cancer…
Jul 19, 2024, 22:19 | Insight
Gautam Mehta summarizes the FDA accelerated approval of fam-trastuzumab deruxtecan-nxki for HER2-mutated NSCLC
FDA oncology shared on X: "OCE's Gautam Mehta and colleagues summarize the FDA accelerated approval…
Jul 3, 2024, 04:18 | Blog
FDA and WHOSTP discuss increasing clinical trials access and lowering barriers to participation
FDA Oncology shared on X: “FDA Oncology Center's Paul Kluetz, Rick Pazdur, Donna Rivera attended…
Jul 1, 2024, 12:51 | Blog
Career Development Beyond the FDA-AACR Oncology Educational Fellowship
FDA Oncology posted on X: "Reflections and Roadmaps: Career Development Beyond the FDA-AACR Oncology Educational Fellowship…
Jan 8, 2024, 09:57 | Insight
Vivek Subbiah: Dr. Timil Patel and colleagues from the FDA Oncology call upon the drug development community to find ways to make clinical trials simpler
Vivek Subbiah shared on X: "Since clinical trials in oncology that are submitted for regulatory…
Oct 9, 2023, 18:54 | Blog
Ishwaria Subbiah: And that’s a wrap! Cheers from your planning committee for the 2023 Workshop on Assessing and Advancing Progress in the Delivery of High-Quality Cancer Care, co-hosted by ASCO and National Cancer Policy Forum!
Oct 1, 2023, 16:07 | Blog
Vivek Subbiah: Fantastic keynote lecture on “The FDA perspective on early phase pre-market dose optimization” by the amazing Dr. Paul Kluetz.
Vivek Subbiah shared on X/Twitter: “Fantastic keynote lecture on “The FDA perspective on early phase pre-market…
All: 11 Posts: 1 - 100
Special Coverage